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suggesting that L domains represent docking sites forBoston, Massachusetts 02115
host proteins. Indeed, it has been reported that the
YPXL-type L domain of EIAV recruits the AP-2 clathrin
adaptor complex (Puffer et al., 1998), and PPXY-typeSummary
L domains have been shown to bind to WW domain-
containing proteins (Freed, 2002). Among these, Nedd4HIV-1 and other retroviruses exit infected cells by
family ubiquitin ligases are of particular interest, be-budding from the plasma membrane, a process requir-
cause the cellular ubiquitin pool is crucial for the releaseing membrane fission. The primary late assembly (L)
of several retroviruses (Vogt, 2000). However, the rolesdomain in the p6 region of HIV-1 Gag mediates the
of AP-2 and of ubiquitin in L domain function remaindetachment of the virion by recruiting host Tsg101, a
poorly understood.component of the class E vacuolar protein sorting
Several recent reports show that the functionally rele-(Vps) machinery. We now show that HIV Gag p6 con-
vant cellular binding partner for PT/SAP-type L domainstains a second region involved in L domain function
is Tsg101 (Demirov et al., 2002a; Garrus et al., 2001;that binds AIP1, a homolog of the yeast class E Vps
Martin-Serrano et al., 2001; VerPlank et al., 2001). Inter-protein Bro1. Further, AIP1 interacts with Tsg101 and
estingly, Tsg101 and its yeast ortholog Vps23 are essen-homologs of a subunit of the yeast class E Vps protein
tial for multivesicular body (MVB) sorting, which involvescomplex ESCRT-III. AIP1 also binds to the L domain
the budding of vesicles into late endosomes in a mannerin EIAV p9, and this binding correlates perfectly with
that is topologically equivalent to retrovirus buddingL domain function. These observations identify AIP1
(Babst et al., 2000). In yeast, MVB sorting requires aas a component of the viral budding machinery, which
total of 17 yeast class E Vps proteins (reviewed in Katz-serves to link a distinct region in the L domain of HIV-1
mann et al., 2002). Vps23 and two other class E Vpsp6 and EIAV p9 to ESCRT-III.
proteins form a cytosolic complex termed ESCRT-I,
which recognizes ubiquitinated endosomal cargo (Katz-Introduction
mann et al., 2001). ESCRT-I activates another soluble
class E Vps complex called ESCRT-II, which in turn isHIV-1 assembly is driven by the Gag polyprotein, which
required to initiate the assembly of the ESCRT-III com-is ultimately cleaved to yield the MA, CA, NC, and p6
plex on endosomal membranes (Babst et al., 2002b).internal structural proteins of the mature virion. HIV-1
ESCRT-III, which appears to be at the core of the appa-and other retroviruses exit infected cells by budding
ratus that drives MVB vesicle formation, is formed byfrom the plasma membrane. During budding, the na-
four structurally related class E Vps proteins that exhibitscent viral capsid becomes enwrapped in a plasma
homology to human CHMP proteins (Babst et al., 2002a;membrane-derived lipid envelope, and a membrane fis-
Howard et al., 2001). To allow further rounds of MVBsion event is thus necessary to separate the virion from
sorting, ESCRT-III recruits the AAA-type ATPase Vps4,
the host cell. This membrane fission event is promoted
a class E Vps protein that disassembles and thereby
by late assembly (L) domains in Gag (reviewed in
recycles the ESCRT machinery (Babst et al., 1998,
Freed, 2002). 2002a). Intriguingly, ATPase-defective Vps4 potently in-
Retroviral L domains have been mapped to three hibits the release of viruses that use PTAP, YPXL, or
classes of tetrapeptide motifs with the sequence PT/ PPXY-type L domains (Garrus et al., 2001; Martin-Ser-
SAP, PPXY, or YPXL. HIV-1 harbors a PT/SAP motif in rano et al., 2003), indicating that elements of the class
the p6 domain of Gag, which is crucial for the detach- E Vps sorting machinery are required for the function
ment of virions from the cell surface and from each other of all types of L domains.
(Demirov et al., 2002b; Gottlinger et al., 1991; Huang et We recently showed that the Tsg101 binding site in
al., 1995). The PT/SAP motif is found at an equivalent HIV-1 p6 does not function autonomously, but needs
position in all lentiviruses except equine infectious ane- to cooperate with other Gag regions to promote virus
mia virus (EIAV), which uses a YPXL motif in the release (Strack et al., 2002). Our results also suggested
C-terminal p9 domain of Gag for virus release (Puffer et that HIV-1 p6 itself contains additional determinants in-
al., 1997). The L domains of other retroviruses have been volved in virus release, because only the full p6 domain
mapped to conserved PPXY motifs in the N-terminal provided L domain activity in the context of a minimal
half of Gag (Wills et al., 1994; Xiang et al., 1996; Yasuda assembly-competent HIV-1 Gag molecule (Accola et al.,
and Hunter, 1998; Yuan et al., 1999). PPXY-type L do- 2000; Strack et al., 2002). We now define a second region
mains are also found in the matrix proteins of rhabdo- within p6 that contributes to the virus release function
of the domain and identify the host protein AIP1 as a
binding partner for this region and for the YPXL-type L*Correspondence: heinrich_gottlinger@dfci.harvard.edu
Cell
690
Figure 1. P6-Mediated Incorporation of AIP1
into VLP
(A) HeLa cells were transfected with 15 g
of proviral DNAs expressing WT and p6 L28A
mutant versions of the uncleaved SIVagm Gag
polyprotein and labeled with [35S]-methio-
nine. VLP pellets were analyzed by SDS-
PAGE and autoradiography. Duplicate sam-
ples were run to demonstrate reproducibility.
(B) Autoradiograph showing the p6-depen-
dent incorporation of a 96 kDa protein into
SIVagm, SIVmac, and HIV-1 VLP produced and
analyzed as in (A).
(C) Immunoblot demonstrating the p6-depen-
dent incorporation of AIP1 into SIVagm VLP.
HeLa cells were cotransfected with 10 g
each of SIVagm Gag and AIP1-HA expression
plasmids, and VLP were produced as in (A).
domain of EIAV. AIP1 (also known as ALIX) was pre- coverage). Eight peptides also matched the KIAA1375
protein, which represents a C-terminal fragment of AIP1.viously identified as an interactor for ALG-2, a calcium
binding protein implicated in apoptosis (Missotten et Importantly, VLP produced by the L28A p6 mutant yielded
no peptides matching AIP1, indicating that the incorpo-al., 1999; Vito et al., 1999). We find that AIP1 also inter-
acts with Tsg101 and with CHMP4 proteins, the human ration of AIP1 into SIVagm VLP is specific. The p6-depen-
dent96 kDa protein in HIV-1 VLP also yielded a total ofhomologs of a yeast ESCRT-III component. Further, we
show that mutant versions of AIP1 and of putative mam- 15 tryptic peptides that matched AIP1 (26.8% coverage).
We thus conclude that the p6 domains of SIVagm andmalian ESCRT-III components arrest both HIV-1 and
EIAV budding. Our results suggest that AIP1 couples HIV-1 both direct the incorporation of AIP1, a ubiqui-
tously expressed 868 residue protein with a conservedHIV-1 p6 and EIAV p9 to the late-acting endosomal sort-
ing complex ESCRT-III. N-terminal Bro1-like domain, predicted coiled-coil do-
mains, and a C-terminal proline- and tyrosine-rich do-
main (Missotten et al., 1999; Vito et al., 1999).Results
To verify that p96 is AIP1, we coexpressed WT SIVagm
Gag or the L28A p6 mutant with HA-tagged AIP1. AIP1-HAP6-Dependent Incorporation of AIP1 into SIV
was readily detected by Western blotting in VLP producedand HIV-1 Particles
by WT SIVagm Gag, but was absent from L28A mutantWe consistently detected a protein of 96 kDa (provi-
VLP (Figure 1C). Since the L28A mutation prevents thesionally designated p96) in [35S]methionine-labeled vi-
incorporation of SIVagm Vpr (Accola et al., 1999), we askedrus-like particles (VLP) produced by the WT SIVagm Gag
whether Vpr affects the uptake of AIP1. While Vpr pro-polyprotein, but not in VLP produced by the L28A p6
vided in trans was incorporated in roughly equimolarmutant (Figure 1A). A protein that comigrated with p96
amounts to Gag, Vpr reduced the uptake of HA-AIP1 bywas also detectable in VLP formed by the Gag polyprot-
less than 10% as quantified by PhosphorImager analysisein of SIVmac (Figure 1B, lane 3), and the removal of the
(data not shown). These data confirm that AIP1 specifi-12 C-terminal p6 residues led to the disappearance of
cally interacts with SIVagm Gag, and indicate that AIP1the band (lane 4). Finally, we compared VLP produced
and Vpr do not efficiently compete for binding to Gag.by the HIV-1 Gag constructs ZWT-p6 and ZWT (Accola et
al., 2000), which differ only in the presence or absence
of a p6 domain. In both constructs, NC is replaced by AIP1 Interacts with a Conserved C-Terminal
Region of HIV-1 p6a leucine zipper domain, which rescues VLP production
in the absence of p6 (Accola et al., 2000). HIV-1 VLP To localize the HIV-1 Gag region that interacts with AIP1,
GST-p6HIV1 was bound to glutathione-Sepharose beadscontaining p6 (lane 5), in contrast to those lacking p6
(lane 6), incorporated a protein that comigrated with and incubated with extract from 293T cells expressing
HA-tagged AIP1. HA-AIP1 was detected in associationp96. These data indicated that the ability to incorporate
p96 in a p6-dependent manner is conserved among with GST-p6HIV1, but not with GST alone (Figure 2A). GST-
p6HIV1 also bound HA-AIP1 that lacked the C-terminalthree widely divergent lineages of primate lentiviruses.
Microsequencing of p96 purified from SIVagm VLP 150 residue proline-rich domain (PRD). Indeed, while
HA-AIP1PRD was less well expressed than full-lengthyielded 15 peptides that matched AIP1/ALIX (21.8%
AIP1 Functions in HIV-1 and EIAV Budding
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Figure 2. Binding of AIP1 to GST-p6
(A) HIV-1 p6 binds full-length AIP1 and AIP1PRD. Beads decorated with GST or GST-p6HIV-1 were incubated with lysates from 293T cells
expressing full-length or C-terminally truncated HA-AIP1, as indicated. Captured proteins, and the cell lysates, were analyzed by Western
blotting with anti-HA antibody. GST and GST-p6 on the beads were monitored by SDS-PAGE and Coomassie staining (bottom).
(B) GST pull-downs performed as in (A) showing that HA-AIP1 binds to a C-terminal region of HIV-1 p6, and to HIV-2 p6.
(C) GST pull-downs performed as in (A) showing that the interaction with AIP1 depends on conserved motifs near the C terminus of HIV-1 p6.
HA-AIP1, GST-p6HIV1 recovered more HA-AIP1PRD than and F45 (LF45PS) was unable to bind to HA-AIP1PRD
(Figure 2C, right). These results demonstrate that theHA-AIP1 from cell extracts (Figure 2A). However, the
removal of an additional 75 residues from the C terminus LXXLF motif is necessary for the in vitro interaction be-
tween HIV-1 p6 and AIP1, whereas the PT/SAP motifresulted in a protein that was no longer able to interact
with GST-p6HIV1 (Figure 2A). is dispensable.
HIV-1 p6 residues 32–46, which are sufficient for AIP1Except for a PT/SAP and a LXXLF motif, which are
widely conserved among primate lentiviruses, the p6 binding, exhibit significant homology to the p6 domain
of SIVcol, which is otherwise highly divergent and lacksdomains of HIV-1 and HIV-2 show little sequence homol-
ogy. Nevertheless, HIV-2 p6 fused to GST bound HA- an evident binding site for Tsg101. In addition to the
LXXLF motif, the region of homology includes the se-AIP1 even more efficiently than HIV-1 p6 (Figure 2B). To
examine the role of the PT/SAP and LXXLF motifs, we quence LYP, which is also found at the core of the EIAV
L domain (see Figure 4A). As shown in Figure 2C (right),expressed fragments of HIV-1 p6 as GST fusion proteins.
GST-p6HIV1(1–41), which retains the PT/SAP motif but small internal deletions in GST-p6HIV1 that affected the
LYP motif (32-36, 34-35, and 37-41) abolished thelacks most of the LXXLF motif, bound only trace
amounts of HA-AIP1 (Figure 2B). In contrast, normalized interaction with HA-AIP1PRD, whereas deleting p6 resi-
dues 27–31 just N-terminal to the LYP motif had nofor the amounts of GST fusion protein on the matrices,
GST-p6HIV1(22–46) and GST-p6HIV1(32–46), which retain effect. We conclude that the LYP motif in HIV-1 p6 forms
part of the primary binding site for AIP1. Of note, theonly the LXXLF motif, bound similar quantities of HA-
AIP1 as full-length GST-p6HIV1 (Figure 2B). 34-35 deletion, which disrupts the AIP1 binding site,
was previously described as an unusual polymorphismTo determine the contribution of the LXXLF motif more
precisely, the conserved residues within the motif were associated with nonprogressive HIV-1 infection (Alexan-
der et al., 2000).substituted individually in the context of full-length GST-
p6HIV1. GST pull-down assays were then performed with
extract from cells expressing HA-AIP1PRD, because the The Primary AIP1 Binding Site Is Required for Efficient
Release of a Minimal HIV-1 Gag Proteinremoval of the proline-rich domain improved the effi-
ciency of the in vitro interaction. One point mutation In a previous study, we observed only a moderate (2-
to 3-fold) decrease in particle production if the primarywithin the LXXLF motif (L41A) nearly completely abol-
ished the interaction with HA-AIP1PRD, L44P was slightly AIP1 binding site was deleted from a full-length HIV-1
provirus (Gottlinger et al., 1991). However, certain de-less disruptive, and F45S had no significant effect (Figure
2C, left). Furthermore, a mutant which lacked both L44 fects in L domain function become apparent only in
Cell
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Figure 3. AIP1 Controls VLP Production by a
Minimal HIV-1 Gag
(A) VLP production by [35S]methionine-labeled
HeLa cells expressing the minimal 8-87/
126–277 HIV-1 Gag molecule with a WT p6
domain or the indicated mutations in p6. VLP
pellets were examined by SDS-PAGE and au-
toradiography, and cell-associated Gag was
detected by immunoprecipitation with anti-
CA serum.
(B) Rescue of VLP production through AIP1
overexpression. HeLa cells were transfected
with 5g proviral DNA encoding8-87/126-
277 HIV-1 Gag with a WT or L41A mutant p6
domain, together with the indicated amounts
of a vector expressing AIP1-HA. Total DNA
was kept constant with empty pBJ5 vector.
VLP production was examined as in (A), and
cell-associated Gag was analyzed by West-
ern blotting with anti-CA serum.
(C) Rescue of VLP production by AIP1PRD in
the absence of the AIP1 binding site. HeLa
cells were transfected with 10 g proviral
DNA encoding8-87/126-277 HIV-1 Gag re-
taining p6 residues 1–52 (WT), 1–35, 1–16, or
no p6 domain, together with 10 g of empty
pBJ5 or HA-AIP1PRD expression vector.
a minimal Gag context (Strack et al., 2002). Thus, we AIP1 did not rescue VLP production by the 1-35 p6
mutant, which lacks the entire primary binding site forexamined the effects of AIP1 binding site mutations in
the context of the 8-87/126-277 HIV-1 Gag protein, AIP1 (data not shown). However, HA-AIP1PRD increased
VLP production by the 1-35 p6 mutant 12-fold (Figurewhich lacks the globular domain of MA and the N-ter-
minal domain of CA, but nevertheless forms particles at 3C). In contrast, HA-AIP1PRD did not increase VLP pro-
duction in the presence of the WT p6 domain (Figureleast as efficiently as the parental HIV-1 provirus (Bor-
setti et al., 1998). As shown in Figure 3A, p6 residues 3C). HA-AIP1PRD also rescued VLP production by the
1-16 p6 mutant, which retains the Tsg101 binding site,1–46, which are sufficient for AIP1 binding (see Figure
2), allowed efficient VLP production in this context. In but had little effect if p6 was deleted entirely (Figure
3C). The ability of HA-AIP1PRD to rescue VLP productioncontrast, C-terminal truncations that preserved only p6
residues 1–41 or 1–35, and thus removed the primary as long as the N-terminal third of p6 was retained raises
the possibility that HA-AIP1PRD acted via Tsg101.AIP1 binding site, reduced VLP production 10-fold or
more (Figure 3A). Similarly, VLP production was signifi-
cantly reduced by point mutations in the LXXLF motif AIP1 Interacts Specifically with the YPXL-Type
L Domain of EIAVthat blocked or severely reduced AIP1 binding (L41A,
L44P, LF45PS), but not by a point mutation (F45S) that EIAV p9 contains a distinct type of L domain that maps
to the sequence YPXL (Puffer et al., 1997). Since thefailed to affect AIP1 binding (Figure 3A). These results
indicate that the L domain function of HIV-1 p6 in a YPXL motif overlaps with a LYP motif (Figure 4A), we
examined whether EIAV p9 interacts with AIP1. Weminimal Gag context depends on AIP1 binding.
Using the 8-87/126-277 minimal Gag context, we found that GST-p9EIAV specifically bound both to full-
length AIP1-HA and to HA-AIP1PRD (Figure 4B). Further-also examined whether VLP production by AIP1 binding
site mutants can be rescued by overexpressing AIP1. more, GST-p9EIAV consistently recovered significantly
more AIP1-HA and HA-AIP1PRD from cell extracts thanWe found that the coexpression of full-length AIP1-HA
increased VLP production by the L41A p6 mutant in a GST-p6HIV1 (Figure 4B and data not shown). To determine
whether the YPXL-type L domain plays a role in thedose-dependent manner (Figure 3B). Full-length HA-
AIP1 Functions in HIV-1 and EIAV Budding
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AIP1 Interacts with Tsg101 and CHMP4 Proteins
A recent report reveals that the yeast AIP1 homolog
Bro1 is a class E Vps protein that is essential for MVB
sorting (Odorizzi et al., 2003). In a systematic analysis
of yeast protein complexes, Bro1 was found associated
with two other class E Vps proteins, Vps32/SNF7 and
Vps4 (Gavin et al., 2002). Vps32 is a component of
ESCRT-III, and Vps4 recycles ESCRT complexes (Babst
et al., 2002a).
Based on these findings, we asked whether AIP1 inter-
acts with mammalian homologs of yeast class E Vps
proteins. In yeast two-hybrid assays, both full-length
AIP1 and AIP1358–868 expressed as GAL4 DBD fusion pro-
teins interacted well with Tsg101 fused to the GAL4 AD
(Figure 5A and data not shown). Furthermore, Tsg101
specifically coprecipitated with FLAG-tagged full-length
AIP1 from 293T cell lysates (Figure 5D), demonstrating
that AIP1 and Tsg101 also interact in human cells.
A database search indicated that yeast Vps32 has
three nearly equally related human homologs: CHMP4A
(BC033859), CHMP4B (BC010893), and CHMP4C
(BC014321). These share 39%, 37%, and 36% amino
acid sequence identity with S. cerevisiae Vps32, respec-
tively. In the yeast two-hybrid system, AIP1 fused to the
GAL4 DBD strongly interacted with CHMP4A or
CHMP4B fused to the GAL4 AD, and these interactions
were confirmed with reciprocal constructs (Figure 5B
and data not shown). CHMP4A also yielded a specific
yeast two-hybrid signal with Vps4A (Figure 5C). To deter-
mine whether AIP1 binds CHMP4A in human cells, HA-
tagged full-length AIP1 was transiently expressed in
293T cells together with FLAG-tagged CHMP4A. As
shown in Figure 5E, CHMP4A-FLAG coprecipitated with
AIP1-HA (lane 3) but not with the cyclophilin A (CyPA)-
HA control (lane 2). Taken together, these data indicate
that AIP1 interacts directly with components of bothFigure 4. AIP1 Binds to the YPXL-Type EIAV L Domain
ESCRT-I and ESCRT-III, and indirectly with Vps4.(A) Alignment of the minimal AIP1 binding site in HIV-1 p6 with
We also asked whether EIAV p9 can recruit CHMP4Athe corresponding region of SIVcol and the core L domain of EIAV.
via AIP1. Glutathione-Sepharose-immobilized GST-Conserved residues are boxed, and EIAV p9 residues required for
budding are marked by arrows. p9EIAV was incubated with extracts from 293T cells ex-
(B) GST pull-downs performed as in Figure 2 showing that EIAV p9 pressing either CHMP4A-FLAG, AIP1-HA, or both. In the
specifically interacts with full-length AIP1 and AIP1PRD. absence of AIP1-HA, GST-p9EIAV retained a small amount(C) GST pull-downs showing that the in vitro interaction with AIP1
of CHMP4A-FLAG (Figure 5F, lane 1), which may haveis absolutely dependent on EIAV p9 residues previously shown to
been recruited via endogenous AIP1. In support of thisbe essential for L domain activity. Residues are marked as in (A).
interpretation, the amount of CHMP4A-FLAG retained
by GST-p9EIAV increased dramatically if AIP1-HA wasinteraction with AIP1, we individually mutated the three
coexpressed (lane 3). The interaction with CHMP4A wascrucial residues in the YPXL motif, as well as two flanking
specific, because GST alone failed to precipitateresidues on either side of the motif. All mutations within
CHMP4A-FLAG even in the presence of AIP1-HA (lanethe YPXL motif that were previously shown to com-
4). These data are compatible with a model in whichpletely abrogate the L domain activity of p9 (Y23A, P24A,
AIP1 couples the EIAV L domain to ESCRT-III.and L26A) (Puffer et al., 1997) also completely abolished
the in vitro interaction between GST-p9EIAV and AIP1 (Fig-
Vps4 Regulates the Interaction between AIP1ure 4C). In contrast, alanine substitutions at three flank-
and CHMP4Aing residues that are not critical for L domain function
The subcellular distribution of yeast Vps32 depends on(N21A, S27A, and E28A) (Puffer et al., 1997) had little if any
the ATPase activity of Vps4 (Babst et al., 1998). To exam-effect on AIP1 binding (Figure 4C). However, L22 just
ine whether the AIP1-CHMP4 interaction is modulatedproximal to the YPXL motif contributed significantly to
by Vps4, we coexpressed AIP1-HA with CHMP4A orthe in vitro interaction with AIP1 (Figure 4C). While not
CHMP4A-FLAG, together with either WT Vps4 or theessential for L domain function, the data of Montelaro
ATPase-defective Vps4AE228Q mutant. After metabolic la-and colleagues indicate that L22 is required for optimal
beling with [35S]methionine, the cells were lysed in 0.5%virus budding (Puffer et al., 1997). These results estab-
NP-40 and AIP1-HA was immunoprecipitated from thelish an excellent correlation between AIP1 binding and
EIAV L domain function. detergent-soluble fraction. Radiolabeled proteins with
Cell
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Figure 5. Interaction of AIP1 with Class E Vps Proteins
(A–C) Yeast two-hybrid assays showing specific interactions between AIP1358-868 and Tsg101 (A), AIP1 and CHMP4A (B), or CHMP4A and
Vps4A (C).
(D) Immunoprecipitations (IP) from 293T cells transiently expressing Tsg101 alone or together with AIP1-FLAG. Proteins precipitated with anti-
FLAG antibody, and the cell lysates were analyzed by Western blotting (WB) as indicated.
(E) Immunoprecipitations from [35S]methionine-labeled 293T cells transiently expressing CHMP4A-FLAG alone or in combination with AIP1-
HA or CyPA-HA. Proteins precipitated with anti-HA antibody were detected by SDS-PAGE and autoradiography, or by Western blotting with
anti-FLAG antibody. Cell lysates were immunoblotted with anti-FLAG antibody.
(F) GST pull-down assays using lysates from 293T cells expressing CHMP4A-FLAG, AIP1-HA, or both proteins. Proteins captured by beads
decorated with GST-p9EIAV or GST alone were detected by Western blotting with anti-HA and anti-FLAG antibodies.
the expected mobilities of CHMP4A-FLAG and CHMP4A CHMP4A becomes trapped in a large detergent-insolu-
ble complex. Furthermore, Vps4AE228Q itself is drawn intoefficiently coprecipitated with AIP1-HA when coex-
pressed with WT Vps4A (Figure 6A, lanes 1 and 3). In- this complex, supporting the conclusion that Vps4 and
CHMP4A interact. Our observations are consistent withdeed, the molar ratio of CHMP4A to AIP1-HA was 1.45
as quantitated by PhosphorImager analysis, indicating previous results indicating that yeast ESCRT-III compo-
nents oligomerize into an insoluble complex in the ab-that AIP1 can interact with a CHMP4A dimer or oligomer.
In striking contrast, radiolabeled CHMP4A or CHMP4A- sence of functional Vps4 (Babst et al., 1998).
FLAG appeared completely absent from AIP1-HA immu-
noprecipitates if Vps4AE228Q was coexpressed (Figure 6A, Inhibition of HIV-1 and EIAV Budding by AIP1
and CHMP Fusion Proteinslanes 4 and 6). Immunoblotting of the immunoprecipi-
tates with anti-FLAG antibody confirmed that Vps4AE228Q AIP1 is predominantly cytosolic (Vito et al., 1999). To
determine the subcellular localization of AIP1PRD, weprevented the coprecipitation of CHMP4A-FLAG with
AIP1-HA (Figure 6A, bottom). replaced the proline-rich domain with red fluorescent
protein (RFP) and observed that AIP1PRD-RFP exhibitedIn the absence of Vps4 function, yeast Vps32 localizes
to a membrane-associated, pelletable fraction that is a diffuse cytoplasmic distribution. In contrast, if the
N-terminal Bro1-like domain of AIP1 was replaced bynot solubilized by Triton X-100 (Babst et al., 1998). Simi-
larly, we found that Vps4AE228Q drastically reduced the RFP, the resulting RFP-AIP1BRO fusion protein localized
exclusively to a few large vesicular structures in theamount of CHMP4A-FLAG in the NP-40 soluble fraction
(data not shown). Even when the cells were lysed in cytoplasm (data not shown).
When AIP1PRD-RFP and RFP-AIP1BRO expressionmore stringent RIPA buffer, CHMP4A-FLAG was found
exclusively in the detergent-insoluble fraction when vectors were cotransfected with the full-length HIV-1
clone HXBH10, we found that both fusion proteins signif-coexpressed with Vps4AE228Q-FLAG (Figure 6B). Further-
more, Vps4AE228Q-FLAG redistributed to the RIPA-insolu- icantly inhibited HIV-1 virion production, as monitored
by the release of particle-associated MA and CA intoble fraction if CHMP4A was coexpressed (Figure 6B).
We infer that Vps4AE228Q blocks the in vivo association the medium (Figure 7A, left). Importantly, neither fusion
protein affected the overall levels of cell-associated Gagbetween detergent-soluble AIP1 and CHMP4A because
AIP1 Functions in HIV-1 and EIAV Budding
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Figure 6. Vps4 Regulates the Interaction be-
tween AIP1 and CHMP4A
(A) Mutant Vps4 blocks the interaction be-
tween soluble AIP1 and CHMP4A. 293T cells
transfected with 3 g of each of the indicated
expression constructs were labeled with
[35S]methionine, lysed in 0.5% NP40 buffer,
and proteins immunoprecipitated with anti-
HA antibody were detected by SDS-PAGE
and autoradiography (top), or by Western
blotting with anti-FLAG antibody (bottom).
(B) Mutant Vps4 causes entrapment of CHMP4A
in a detergent-insoluble complex. 293T cells
transfected with 3 g of each of the indicated
expression constructs were partitioned into
RIPA-soluble and -insoluble (pellet) fractions,
which were analyzed by Western blotting with
anti-FLAG antibody.
(Figure 7A, right). However, both reproducibly altered CHMP4C-RFP had a less dramatic effect, but still re-
duced HIV-1 release more than 30-fold (lane 4). Whilethe ratio of mature CA versus the CA-p2 processing
intermediate and caused an accumulation of the p41 the fusion proteins had no or only a moderate effect on
the cell-associated Gag protein levels, they all de-Gag processing intermediate, as is typically seen if a
late assembly step is defective (Garrus et al., 2001; Gott- creased the amount of mature CA relative to the CA-p2
processing intermediate, as expected for a late assem-linger et al., 1991). AIP1PRD-RFP also dramatically re-
duced particle production by the EIAV Gag polyprotein bly defect (Figure 7B, right).
CHMP3-RFP also blocked particle production by EIAVwithout affecting the steady-state levels of cell-associ-
ated Gag (Figure 7C, lane 3). Gag at a 1:1 DNA ratio (Figure 7C, lane 4), while the
EIAV Gag expression levels remained comparable toBecause AIP1 interacts with CHMP4 proteins, we also
tested the effects of CHMP-RFP fusion proteins on viral those obtained with the RFP control. At the same DNA
ratio, CHMP4A-RFP blocked EIAV VLP production butparticle formation, based on the finding that the family
member CHMP1 can be converted into a dominant- also reduced Gag expression levels (data not shown).
However, EIAV Gag expression was no longer affectednegative form by fusing its C terminus to GFP (Howard
et al., 2001). We fused RFP to the C termini of CHMP3 if the amount of CHMP4A-RFP DNA was lowered 10-
fold, whereas VLP production remained nearly com-and CHMP4, whose yeast homologs are components
of different subcomplexes of ESCRT-III (Babst et al., pletely blocked (Figure 7C, lane 6).
Thin section electron microscopy revealed that2002a). Even when 293T cells were cotransfected with
the CHMP3-RFP expressor and HXBH10 at a DNA ratio AIP1PRD-RFP and RFP-AIP1BRO both induced an accu-
mulation of HIV-1 budding structures and immature par-as low as 1:6, HIV-1 virion production from the full-length
provirus was blocked, and instead significant quantities ticles at the cell surface, indicating that HIV-1 assembly
was inhibited at a late stage (Figure 7D, top). We alsoof CHMP3-RFP were released in a pelletable form (Fig-
ure 7B, lane 3). HIV-1 virion release was also blocked examined the effect of AIP1PRD-RFP on EIAV budding.
Extensive electron-dense plaques that appeared to beby CHMP4A-RFP (lane 5). At the 1:6 input DNA ratio,
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Figure 7. AIP1 and CHMP Fusion Proteins In-
hibit HIV-1 and EIAV Budding
(A) AIP1-RFP fusion proteins inhibit HIV-1 re-
lease. 293T cells were cotransfected with 1.5
g HXBH10, which encodes WT HIV-1, and
1 g of RFP or RFP fusion protein expression
vectors as indicated. Virus pellets and cell
lysates were analyzed by Western blotting
with AIDS patient serum and anti-CA se-
rum, respectively.
(B) CHMP-RFP fusion proteins inhibit HIV-1
release. 293T cells were cotransfected with
1.25 g HXBH10 and 0.2 g of RFP or RFP
fusion protein expression vectors as indi-
cated, and labeled with [35S]methionine. Virus
pellets were analyzed by SDS-PAGE and au-
toradiography, and cell lysates by immuno-
precipitation with anti-CA serum.
(C) AIP1- and CHMP-RFP fusion proteins in-
hibit the release of EIAV VLP. 293T cells were
transfected with 1 g of a proviral construct
encoding the EIAV Gag polyprotein, together
with 1 g (lanes 1–4) or 0.1 g (lanes 5 and 6)
of the indicated RFP and RFP fusion protein
expression vectors. VLP pellets and cell ly-
sates were analyzed by Western blotting with
a mix of anti-EIAV MA and CA sera.
(D) AIP1 and CHMP fusion proteins arrest
HIV-1 and EIAV budding. Thin sections of
293T cells transiently expressing WT HIV-1
or EIAV Gag together with the indicated AIP1-
or CHMP-RFP fusion proteins were examined
by electron microscopy. Scale bars are equal
to 250 nm.
(E) Model for HIV-1 late domain function. The
p6 domain forms a ternary complex with AIP1
and ESCRT-I component Tsg101, which then
recruits CHMP proteins directly via AIP1 and
indirectly via ESCRT-II to form ESCRT-III. The
wavy lines symbolize myristyl groups.
confluent viral budding structures were observed at the We find that AIP1 interacts with human homologs of a
yeast ESCRT-III component (Babst et al., 2002a), andplasma membrane, sometimes covering nearly the en-
that the interaction is prevented by mutant Vps4 pre-tire circumference of a cell (Figure 7D, middle). Thus,
viously reported to block HIV-1 and EIAV particle forma-AIP1PRD-RFP allowed the assembly of EIAV Gag at the
tion (Garrus et al., 2001; Martin-Serrano et al., 2003).plasma membrane, but bud formation appeared ar-
Furthermore, dominant-negative forms of AIP1 and ofrested at an early stage.
putative mammalian ESCRT-III components potently in-Consistent with a defect at a very late stage of bud-
hibited HIV-1 and EIAV budding, indicating that AIP1ding, cells coexpressing wild-type HIV-1 and CHMP4A-
and a functional ESCRT-III complex have central rolesRFP or CHMP3-RFP displayed numerous particles of
in the activity of lentiviral L domains.immature appearance at the outer surface of the cell
Although some of the determinants required for AIP1membrane, and a similar phenotype was observed when
binding by HIV-1 p6 are lacking in HIV-2 and other pri-EIAV Gag was coexpressed with CHMP3-RFP (Figure
mate lentiviruses, our results indicate that the ability to7D, bottom). These observations imply that an intact
bind to AIP1 is widely if not universally conserved amongESCRT-III complex is required to sever the budding virus
these viruses. The role of the AIP1 binding site in HIV-1from the cell surface.
p6 appears to be somewhat cell-type dependent, since
its removal from a full-length HIV-1 provirus caused a
Discussion 2- to 3-fold defect in HIV-1 release in COS-7 cells but
not in HeLa cells (Demirov et al., 2002b; Gottlinger et
We have identified AIP1 as a host protein that links al., 1991). However, even in HeLa cells, the AIP1 binding
HIV-1 p6 and EIAV p9 to a late-acting endosomal sorting site becomes essential for L domain activity in the ab-
complex essential for viral budding. The yeast AIP1 ho- sence of certain MA and CA sequences (Figure 3). A
molog Bro1 was recently shown to be required for the particle production defect caused by a point mutation
MVB pathway and was proposed to function in concert in the AIP1 binding site could be rescued by overex-
pressing AIP1, indicating that inefficient AIP1 bindingwith or downstream of ESCRT-III (Odorizzi et al., 2003).
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accounted for the defect. It is conceivable that MA and/ and CHMP4. Because the apparent yeast orthologs are
or CA contain regions that are functionally redundant found in different ESCRT-III subcomplexes (Babst et al.,
with the AIP1 binding site in p6. The possibility that 2002a), our observations implicate the whole ESCRT-III
interaction sites for class E Vps proteins are not limited complex in lentiviral budding.
to p6 is suggested by the conservation of a PTAP motif L domains are thought to engage the machinery nec-
among HIV-2 and SIVmac MA proteins. Moreover, we note essary to sever the viral lipid envelope from the cell
that visna lentivirus and bovine immunodeficiency virus surface. Consistent with a requirement for a functional
have a consensus AIP1 binding site (L/IYPXL) at or near ESCRT-III complex at this step, a CHMP3 fusion protein
the C terminus of MA. blocked both HIV-1 and EIAV release at a very late stage.
We find that AIP1 also interacts with Tsg101, which An AIP1 fusion protein also blocked the final step of
binds to the PTAP-type L domain near the N terminus HIV-1 release, but arrested EIAV budding at an earlier
of p6. Since HIV-1 budding cannot occur in the absence stage. Interestingly, it was recently shown that the
of Tsg101 (Garrus et al., 2001), we favor a model in which PPXY-type L domain of HTLV-I is required early in the
the formation of a ternary complex between HIV-1 p6, budding process (Le Blanc et al., 2002), indicating that
Tsg101, and AIP1 is required for efficient ESCRT-III re- the role of L domains is not always limited to the induc-
cruitment (Figure 7E). Remarkably, as long as the Tsg101 tion of membrane fusion at the neck of budding parti-
binding site was retained, AIP1PRD potently rescued par- cles. Our observations raise the possibility that AIP1
ticle production by a minimal HIV-1 Gag molecule that also assists in the induction of membrane curvature by
lacked the entire AIP1 binding site, lending support to EIAV Gag. In this regard, it may be relevant that AIP1
the notion that AIP1 functions in concert with Tsg101. strongly interacts with endophilins, a family of endocytic
Furthermore, our observation that full-length AIP1 was proteins thought to be involved in the induction of mem-
inactive in this context suggests a negative regulatory brane curvature (Chatellard-Causse et al., 2002).
role for the proline-rich domain. Factors that bind to PPXY-type L domains are thought to function as dock-
this domain, such as endophilins or the adaptor protein ing sites for Nedd4 family ubiquitin ligases (Freed, 2002).
CIN85/RUK/SETA (Chatellard-Causse et al., 2002; Chen It is therefore intriguing that the yeast Nedd4 homolog
et al., 2000), may thus modulate the activity of AIP1. Rsp5 and the AIP1 homolog Bro1 are both required
Our results show that AIP1 binds tightly to EIAV p9, for the ubiquitin-dependent downregulation of the Gap1
which is functionally equivalent to HIV-1 p6. Importantly, permease (Springael et al., 2002). Furthermore, genetic
each residue previously shown to be required for the L interactions between Rsp5 and Bro1 mutations support
domain function of p9 (Puffer et al., 1997) is essential the proposal that the two proteins act together in a
for AIP1 binding. In contrast, binding to the medium complex (Forsberg et al., 2001; Springael et al., 2002).
chain of AP-2, a previously reported candidate interactor This suggests that PPXY-type L domains may recruit
for the EIAV L domain, was reduced but not abolished AIP1 indirectly via an associated Nedd4 family member,
by mutations in the YPXL motif (Puffer et al., 1998). Thus, and thus may ultimately engage components of the
we infer that AIP1 is the functionally relevant binding same cellular pathway used by other types of L domains.
partner for the EIAV L domain.
The apparent affinity of EIAV p9 for AIP1 in pull-down
Experimental Procedures
assays was significantly higher than that of HIV-1 p6.
The presence of a more efficient AIP1 binding site in Proviral Constructs
EIAV p9 may compensate for the absence of a Tsg101 HXBH10 harbors a full-length HIV-1 provirus (Accola et al., 2000).
Previously described HXBH10-based constructs were used to ex-binding site. Consistent with this view, the LYPXL motif,
press WT and p6 mutant versions of the SIVagm and SIVmac Gagwhich mediates the interaction between EIAV p9 and
polyproteins, or the Vpr protein of SIVagm (Accola et al., 1999). ZWTAIP1, is also found in the p6 domain of SIVcol, the only
expresses an HIV-1 Gag precursor that has NC and p6 replaced byprimate lentivirus known to lack a binding site for
a leucine zipper, which rescues VLP production, and ZWT-p6 is a
Tsg101. A recent report reveals that the sequence YPXL variant of ZWT that has HIV-1 p6 appended to the leucine zipper
represents an interaction motif for PalA, an Aspergillus domain (Accola et al., 2000). Mutations into the p6-coding region
nidulans homolog of AIP1 that functions in the ambient of a protease-defective version of the 8-87/126-277 minimal Gag
construct (Borsetti et al., 1998) were introduced by site-directedpH signal transduction pathway (Vincent et al., 2003).
mutagenesis. A construct expressing the EIAV Gag polyprotein wasThese findings indicate that EIAV p9 recruits AIP1
obtained by inserting a fragment (nt 326–1933) harboring the gagthrough a motif that has been conserved as a binding
gene of EIAV clone 1369 between nt 637 and 5228 of HXBH10.epitope for AIP1 family members throughout eukary-
otic evolution.
Mammalian Expression PlasmidsWe demonstrate that EIAV p9 can efficiently recruit
EST clones encoding AIP1 (AL541110), CHMP3 (BC004419),
CHMP4A via AIP1. These data are compatible with a CHMP4A (BC011429), CHMP4B (BC010893), CHMP4C (BC014321),
model in which a high affinity interaction between AIP1 and Vps4A (AL582940) were purchased from Resgen (Invitrogen).
and the EIAV L domain is sufficient to trigger the forma- DNAs encoding full-length AIP1 bearing an N- or C-terminal HA or
tion of ESCRT-III at sites of EIAV budding. Consistent a C-terminal FLAG epitope, or AIP1 residues 1–702 with an N-ter-
minal HA epitope (HA-AIP1PRD), or full-length CHMP4A or Vps4Awith this model, a recent report shows that EIAV budding
with or without a C-terminal FLAG epitope were amplified and in-does not require an intact ESCRT-I complex, but is nev-
serted into the mammalian expression vector pBJ5. All constructsertheless blocked by dominant-negative Vps4 (Martin-
were verified by sequencing the entire insert. The E228Q mutation
Serrano et al., 2003), which prevents the recycling of was introduced into the Vps4A-FLAG expression vector by PCR-
ESCRT-III (Babst et al., 2002a). A role for ESCRT-III in based mutagenesis. The pBJ5-based expression vector for HA-
EIAV (and HIV-1) budding is also suggested by our find- tagged cyclophilin A was a gift from Richard Bram (Rochester, MI).
DNA encoding AIP1 residues 1–702 or full-length CHMP3, CHMP4A,ing that particle production is blocked by mutant CHMP3
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or CHMP4C was also inserted into pDSRed2-N1 (Clontech) to gener- Electron Microscopy
Transfected 293T cells were fixed for 1 hr in 2.5% glutaraldehyde,ate expression vectors for AIP1PRD-RFP, CHMP3-RFP, CHMP4A-
RFP, and CHMP4C-RFP, respectively. DNA encoding AIP1 residues postfixed with 1% osmium tetroxide/1.5% potassium ferrocyanide,
stained in 1% aqueous uranyl acetate, dehydrated in grades of358–868 was cloned into pDSRed2-C1, yielding an expression vec-
tor for RFP-AIP1BRO. ethanol, and embedded in TAAB Epon (Marivac Canada Inc.). Ultra-
thin sections were stained with uranyl acetate and lead citrate, and
examined in a JEOL 1200EX transmission electron microscope.
VLP Analysis
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